Skip to content

RA CAPITAL MANAGEMENT, L.P.

Follow

13F filer, CIK 1346824, BOSTON, MA

RA CAPITAL MANAGEMENT, L.P. reported $9,969,410,191 across 92 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 61.29% of the portfolio.

Accepted , ingested 13F-HR 0001104659-26-128411

Period
2026-09-30
Reported value
$9.97B
Holdings
92
Top 10 weight
61.29%
New
21
Sold out
13

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • BBTX BAMBUSA THERAPEUTICS INC: 13D 7,429,758 shares, 14.6% of the class, 13D filed 2026-11-06, 0001346824-26-000253Timeline
    Accepted , ingested
  • TCXB TCGX ACQUISITION CORP II: 13G 750,000 shares, 7.2% of the class, 13G filed 2026-10-26, 0001346824-26-000249Timeline
    Accepted , ingested
  • ALEC ALECTOR INC: 13G 7,500,000 shares, 5.1% of the class, 13G filed 2026-10-26, 0001346824-26-000247Timeline
    Accepted , ingested
  • FLSC FRAZIER LIFE SCIENCES ACQ-A: 13G 700,000 shares, 9% of the class, 13G filed 2026-10-22, 0001346824-26-000245Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
FRNMnew+15,367,270$242M
AMLXnew+4,279,341$125M
WVEnew+26,975,505$99.8M
LTGOnew+5,302,933$88.6M
OBXnew+5,957,103$81.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BCRXexited-15,827,186-$158M
WVEexited-26,975,505-$157M
NUVLexited-1,246,456-$154M
GHRSreduced-4,027,806-$94.6M
ZLABreduced-2,927,990-$77.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001104659-26-128411, largest first. % of portfolio is the value over $9,969,410,191, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,281,496 shares; 2026Q3: 10,281,496 shares 10,281,496$2.34B23.5%0Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 28,933,371 shares; 2026Q3: 29,177,964 shares 29,177,964$942M9.45%+244,593Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,689,190 shares; 2025Q1: 12,189,149 shares; 2025Q2: 11,965,991 shares; 2025Q3: 11,965,991 shares; 2025Q4: 10,724,599 shares; 2026Q1: 11,474,599 shares; 2026Q2: 11,474,599 shares; 2026Q3: 11,474,599 shares 11,474,599$653M6.55%0Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,084,412 shares; 2025Q1: 6,084,412 shares; 2025Q2: 5,561,359 shares; 2025Q3: 5,681,359 shares; 2025Q4: 6,666,837 shares; 2026Q1: 6,666,837 shares; 2026Q2: 6,666,837 shares; 2026Q3: 6,666,837 shares 6,666,837$635M6.37%0Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,909,091 shares; 2025Q1: 8,909,091 shares; 2025Q2: 9,902,633 shares; 2025Q3: 10,428,437 shares; 2025Q4: 10,428,437 shares; 2026Q1: 10,428,437 shares; 2026Q2: 8,392,730 shares; 2026Q3: 8,392,730 shares 8,392,730$341M3.42%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,637,290 shares; 2025Q1: 10,637,290 shares; 2025Q2: 12,198,625 shares; 2025Q3: 12,198,625 shares; 2025Q4: 12,198,625 shares; 2026Q1: 12,198,625 shares; 2026Q2: 12,198,625 shares; 2026Q3: 12,198,625 shares 12,198,625$267M2.68%0Timeline
FRNMFREENOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 15,367,270 shares 15,367,270$242M2.43%newTimeline
COAGHEMAB THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 7,808,627 shares; 2026Q3: 7,808,627 shares 7,808,627$241M2.42%0Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,845,000 shares; 2025Q1: 10,138,938 shares; 2025Q2: 10,138,938 shares; 2025Q3: 10,138,938 shares; 2025Q4: 9,550,191 shares; 2026Q1: 9,550,191 shares; 2026Q2: 9,550,191 shares; 2026Q3: 9,550,191 shares 9,550,191$232M2.33%0Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,995,858 shares; 2025Q1: 6,995,858 shares; 2025Q2: 6,995,858 shares; 2025Q3: 6,995,858 shares; 2025Q4: 6,995,858 shares; 2026Q1: 6,995,858 shares; 2026Q2: 6,995,858 shares; 2026Q3: 5,502,858 shares 5,502,858$215M2.16%-1,493,000Timeline
SGPSPYGLASS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 8,021,117 shares; 2026Q2: 8,021,117 shares; 2026Q3: 8,021,117 shares 8,021,117$209M2.09%02026-11-16, Form 4: bought 1,000 shares on 2026-11-16 Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,365,652 shares; 2025Q1: 11,189,693 shares; 2025Q2: 11,189,693 shares; 2025Q3: 11,189,693 shares; 2025Q4: 11,189,693 shares; 2026Q1: 11,189,693 shares; 2026Q2: 11,189,693 shares; 2026Q3: 11,189,693 shares 11,189,693$193M1.94%0Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,850,984 shares; 2025Q1: 6,147,280 shares; 2025Q2: 6,147,280 shares; 2025Q3: 7,323,750 shares; 2025Q4: 7,323,750 shares; 2026Q1: 7,692,750 shares; 2026Q2: 7,692,750 shares; 2026Q3: 7,692,750 shares 7,692,750$193M1.94%0Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,577,106 shares; 2025Q2: 1,577,106 shares; 2025Q3: 1,577,106 shares; 2025Q4: 1,976,132 shares; 2026Q1: 2,450,221 shares; 2026Q2: 2,450,221 shares; 2026Q3: 2,450,221 shares 2,450,221$160M1.61%0Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,872,503 shares; 2025Q1: 10,872,503 shares; 2025Q2: 23,555,648 shares; 2025Q3: 23,555,648 shares; 2025Q4: 23,555,648 shares; 2026Q1: 23,555,648 shares; 2026Q2: 23,555,648 shares; 2026Q3: 30,435,190 shares 30,435,190$148M1.49%+6,879,542Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,955,993 shares; 2025Q1: 6,955,993 shares; 2025Q2: 6,955,993 shares; 2025Q3: 6,955,993 shares; 2025Q4: 6,955,993 shares; 2026Q1: 7,255,993 shares; 2026Q2: 7,255,993 shares; 2026Q3: 7,255,993 shares 7,255,993$135M1.35%0Timeline
ARTVARTIVA BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,853,302 shares; 2025Q1: 9,853,302 shares; 2025Q2: 9,853,302 shares; 2025Q3: 9,853,302 shares; 2025Q4: 9,853,302 shares; 2026Q1: 9,853,302 shares; 2026Q2: 17,955,642 shares; 2026Q3: 18,489,293 shares 18,489,293$132M1.32%+533,651Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 575,000 shares; 2025Q1: 575,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,897,237 shares; 2026Q2: 5,274,274 shares; 2026Q3: 5,274,274 shares 5,274,274$132M1.32%0Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,554,597 shares; 2026Q3: 1,554,597 shares 1,554,597$129M1.3%0Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,279,341 shares 4,279,341$125M1.25%newTimeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 31,419,267 shares; 2025Q1: 31,419,267 shares; 2025Q2: 31,419,267 shares; 2025Q3: 31,419,267 shares; 2025Q4: 11,293,828 shares; 2026Q1: 11,300,939 shares; 2026Q2: 11,300,939 shares; 2026Q3: 10,130,130 shares 10,130,130$116M1.17%-1,170,8092026-11-05, 13D/A: 23,941,277 shares, 33% of the class, 13D/A filed 2026-11-09 Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,132,557 shares; 2026Q3: 1,030,058 shares 1,030,058$102M1.02%-102,499Timeline
WVEWAVE LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 26,975,505 shares 26,975,505$99.8M1%new2026-10-05, Form 4: granted 10,700 shares on 2026-10-05 Timeline
LTGOLATIGO BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 5,302,933 shares 5,302,933$88.6M0.89%newTimeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,330,446 shares; 2025Q1: 4,330,446 shares; 2025Q2: 5,811,323 shares; 2025Q3: 5,811,423 shares; 2025Q4: 5,811,423 shares; 2026Q1: 9,339,978 shares; 2026Q2: 12,036,126 shares; 2026Q3: 12,036,126 shares 12,036,126$87M0.87%02026-11-04, 13D/A: 12,036,126 shares, 10.8% of the class, 13D/A filed 2026-11-06 Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,982,301 shares; 2025Q4: 5,404,998 shares; 2026Q1: 5,404,998 shares; 2026Q2: 2,402,095 shares; 2026Q3: 4,503,882 shares 4,503,882$85.9M0.86%+2,101,787Timeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,776,958 shares; 2025Q4: 2,208,604 shares; 2026Q1: 2,208,604 shares; 2026Q2: 2,208,604 shares; 2026Q3: 2,208,604 shares 2,208,604$84.8M0.85%0Timeline
GHRSGH RESEARCH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,686,689 shares; 2025Q1: 6,944,648 shares; 2025Q2: 7,676,697 shares; 2025Q3: 7,676,697 shares; 2025Q4: 7,676,697 shares; 2026Q1: 7,676,697 shares; 2026Q2: 7,636,813 shares; 2026Q3: 3,609,007 shares 3,609,007$84.7M0.85%-4,027,806Timeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 5,957,103 shares 5,957,103$81.8M0.82%newTimeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,295,040 shares; 2025Q1: 1,295,040 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,707,262 shares; 2026Q2: 5,743,533 shares; 2026Q3: 2,815,543 shares 2,815,543$74.2M0.74%-2,927,990Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,563,211 shares; 2025Q1: 4,563,211 shares; 2025Q2: 4,563,211 shares; 2025Q3: 4,563,211 shares; 2025Q4: 5,653,211 shares; 2026Q1: 5,049,779 shares; 2026Q2: 5,049,779 shares; 2026Q3: 5,049,779 shares 5,049,779$72.3M0.72%0Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,666,667 shares; 2025Q1: 4,666,667 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,804,072 shares; 2026Q2: 12,723,026 shares; 2026Q3: 12,723,026 shares 12,723,026$66.9M0.67%0Timeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 18,750,000 shares; 2026Q3: 18,750,000 shares 18,750,000$54.7M0.55%0Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 511,207 shares; 2025Q1: 511,207 shares; 2025Q2: 511,207 shares; 2025Q3: 511,207 shares; 2025Q4: 667,207 shares; 2026Q1: 667,207 shares; 2026Q2: 667,207 shares; 2026Q3: 667,207 shares 667,207$53.2M0.53%0Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 30,009,536 shares; 2025Q1: 60,379,366 shares; 2025Q2: 60,379,366 shares; 2025Q3: 60,379,366 shares; 2025Q4: 63,771,366 shares; 2026Q1: 63,771,366 shares; 2026Q2: 42,809,751 shares; 2026Q3: 42,754,145 shares 42,754,145$52.6M0.53%-55,606Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,399,702 shares 2,399,702$51.1M0.51%newTimeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,689,545 shares; 2025Q1: 10,689,545 shares; 2025Q2: 10,689,545 shares; 2025Q3: 20,064,545 shares; 2025Q4: 20,064,545 shares; 2026Q1: 20,064,545 shares; 2026Q2: 20,064,545 shares; 2026Q3: 20,064,545 shares 20,064,545$48.6M0.49%02026-11-13, 13D/A: 28,742,212 shares, 30.5% of the class, 13D/A filed 2026-11-17 Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,860,977 shares; 2025Q1: 10,860,977 shares; 2025Q2: 10,860,977 shares; 2025Q3: 10,860,977 shares; 2025Q4: 10,860,977 shares; 2026Q1: 10,860,977 shares; 2026Q2: 10,860,977 shares; 2026Q3: 10,860,977 shares 10,860,977$46.8M0.47%0Timeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 14,932,063 shares; 2025Q1: 14,932,063 shares; 2025Q2: 14,932,063 shares; 2025Q3: 14,932,063 shares; 2025Q4: 14,932,063 shares; 2026Q1: 20,992,669 shares; 2026Q2: 20,992,669 shares; 2026Q3: 20,992,669 shares 20,992,669$46.6M0.47%0Timeline
DBVTDBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,657,644 shares 3,657,644$43M0.43%newTimeline
AGENAGENUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,122,000 shares 4,122,000$40.9M0.41%newTimeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 9,180,000 shares; 2026Q1: 9,180,000 shares; 2026Q2: 9,445,039 shares; 2026Q3: 9,445,039 shares 9,445,039$39.1M0.39%0Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 10,445,322 shares; 2025Q2: 10,445,322 shares; 2025Q3: 10,445,322 shares; 2025Q4: 9,905,045 shares; 2026Q1: 9,905,045 shares; 2026Q2: 9,905,045 shares; 2026Q3: 6,456,234 shares 6,456,234$34M0.34%-3,448,811Timeline
SCTXSCRIBE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,802,178 shares 1,802,178$33.2M0.33%newTimeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 17,754,430 shares; 2026Q2: 17,754,430 shares; 2026Q3: 17,754,430 shares 17,754,430$30.4M0.3%0Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,458,770 shares; 2026Q1: 3,494,638 shares; 2026Q2: 3,494,638 shares; 2026Q3: 3,494,638 shares 3,494,638$28.9M0.29%02026-11-06, 13D/A: 3,494,638 shares, 8.5% of the class, 13D/A filed 2026-11-10 Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 892,743 shares 892,743$28.6M0.29%newTimeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,507,844 shares; 2026Q1: 1,507,844 shares; 2026Q2: 1,507,844 shares; 2026Q3: 3,014,183 shares 3,014,183$28.5M0.29%+1,506,339Timeline
NKTXNKARTA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,805,129 shares; 2025Q1: 10,805,129 shares; 2025Q2: 10,805,129 shares; 2025Q3: 10,805,129 shares; 2025Q4: 10,805,129 shares; 2026Q1: 10,805,129 shares; 2026Q2: 10,805,129 shares; 2026Q3: 10,805,129 shares 10,805,129$28.3M0.28%0Timeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,878,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,000,000 shares; 2026Q1: 8,000,000 shares; 2026Q2: 8,000,000 shares; 2026Q3: 8,194,779 shares 8,194,779$27.3M0.27%+194,779Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,062,326 shares; 2025Q3: 1,062,326 shares; 2025Q4: 3,671,083 shares; 2026Q1: 3,671,083 shares; 2026Q2: 3,671,083 shares; 2026Q3: 1,835,542 shares 1,835,542$25.8M0.26%-1,835,541Timeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,475,882 shares; 2026Q3: 6,475,882 shares 6,475,882$25.3M0.25%0Timeline
ACRVACRIVON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,340,508 shares; 2025Q1: 8,340,508 shares; 2025Q2: 8,340,508 shares; 2025Q3: 8,340,508 shares; 2025Q4: 8,340,508 shares; 2026Q1: 8,340,508 shares; 2026Q2: 12,229,396 shares; 2026Q3: 12,229,396 shares 12,229,396$25.1M0.25%0Timeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,020,410 shares; 2025Q4: 1,020,410 shares; 2026Q1: 1,020,410 shares; 2026Q2: 1,020,410 shares; 2026Q3: 1,020,410 shares 1,020,410$24M0.24%0Timeline
EDITEDITAS MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 8,889,000 shares; 2026Q3: 8,889,000 shares 8,889,000$22.8M0.23%0Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,332,457 shares; 2026Q3: 2,332,457 shares 2,332,457$19.3M0.19%0Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,000,000 shares; 2026Q2: 3,000,000 shares; 2026Q3: 2,474,076 shares 2,474,076$19.2M0.19%-525,924Timeline
ETRAELECTRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,692,965 shares 1,692,965$19M0.19%newTimeline
ALTALTIMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,500,000 shares; 2026Q3: 6,500,000 shares 6,500,000$18.6M0.19%0Timeline
BNTCBENITEC BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,850,000 shares; 2026Q1: 1,850,000 shares; 2026Q2: 1,850,000 shares; 2026Q3: 1,850,000 shares 1,850,000$18.5M0.19%0Timeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 13,011,849 shares; 2026Q2: 13,011,849 shares; 2026Q3: 13,011,849 shares 13,011,849$18.1M0.18%0Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,800,000 shares 1,800,000$17.8M0.18%newTimeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 546,554 shares; 2025Q1: 546,554 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,000,000 shares; 2026Q1: 5,000,000 shares; 2026Q2: 5,000,000 shares; 2026Q3: 5,000,000 shares 5,000,000$16.9M0.17%0Timeline
LENZLENZ THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,178,823 shares; 2025Q1: 4,178,823 shares; 2025Q2: 4,178,823 shares; 2025Q3: 4,178,823 shares; 2025Q4: 4,178,823 shares; 2026Q1: 4,178,823 shares; 2026Q2: 4,178,823 shares; 2026Q3: 4,178,823 shares 4,178,823$16M0.16%02026-10-29, 13D/A: 70,533 shares, 0.2% of the class, 13D/A filed 2026-11-02 Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,500,000 shares; 2026Q3: 2,500,000 shares 2,500,000$15.7M0.16%0Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 967,000 shares; 2025Q1: 967,000 shares; 2025Q2: 932,973 shares; 2025Q3: 662,968 shares; 2025Q4: 662,968 shares; 2026Q1: 662,968 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000$15.3M0.15%0Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 6,970,000 shares 6,970,000$14.3M0.14%newTimeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,901,960 shares 4,901,960$14.3M0.14%newTimeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 700,000 shares; 2026Q3: 700,000 shares 700,000$14.1M0.14%0Timeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,401,500 shares; 2025Q4: 4,401,500 shares; 2026Q1: 4,401,500 shares; 2026Q2: 4,401,500 shares; 2026Q3: 4,401,500 shares 4,401,500$14M0.14%0Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,714,000 shares; 2026Q1: 10,714,000 shares; 2026Q2: 10,500,968 shares; 2026Q3: 5,598,200 shares 5,598,200$13.9M0.14%-4,902,768Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 318,554 shares; 2026Q2: 318,554 shares; 2026Q3: 159,278 shares 159,278$13.6M0.14%-159,276Timeline
HLXCHELIX ACQUISITION CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,250,000 shares; 2026Q2: 1,250,000 shares; 2026Q3: 1,250,000 shares 1,250,000$13.3M0.13%0Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 460,829 shares; 2025Q1: 206,427 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 265,000 shares; 2026Q2: 265,000 shares; 2026Q3: 265,000 shares 265,000$13.2M0.13%0Timeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,914,788 shares 1,914,788$13.1M0.13%newTimeline
BRVEBRAVEHEART BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 565,000 shares 565,000$11.4M0.11%newTimeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,998,333 shares; 2026Q2: 3,998,333 shares; 2026Q3: 3,998,333 shares 3,998,333$10.9M0.11%0Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,124,116 shares; 2026Q1: 7,124,116 shares; 2026Q2: 7,124,116 shares; 2026Q3: 7,124,116 shares 7,124,116$9.62M0.1%0Timeline
INOINOVIO PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 7,220,384 shares 7,220,384$8.81M0.09%newTimeline
MGNXMACROGENICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,864,176 shares; 2026Q2: 1,864,176 shares; 2026Q3: 1,864,176 shares 1,864,176$7.2M0.07%0Timeline
RANIRANI THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,500,000 shares; 2026Q1: 8,500,000 shares; 2026Q2: 8,500,000 shares; 2026Q3: 8,500,000 shares 8,500,000$6.72M0.07%0Timeline
ACETADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 948,249 shares; 2026Q1: 1,182,624 shares; 2026Q2: 932,624 shares; 2026Q3: 932,624 shares 932,624$6.66M0.07%0Timeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000$6.25M0.06%newTimeline
FTHFAETH THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 722,020 shares; 2026Q3: 205,060 shares 205,060$6.1M0.06%-516,960Timeline
JATTJATT II ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000$5.62M0.06%0Timeline
JTTTJATT III ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000$4.96M0.05%newTimeline
NAMSWNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 333,333 shares; 2025Q1: 333,333 shares; 2025Q2: 333,333 shares; 2025Q3: 333,333 shares; 2025Q4: 333,333 shares; 2026Q1: 333,333 shares; 2026Q2: 333,333 shares; 2026Q3: 333,333 shares 333,333$4.22M0.04%0Timeline
AMANAMANAT ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 375,000 shares; 2026Q3: 375,000 shares 375,000$4M0.04%0Timeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,096,336 shares; 2026Q2: 3,096,336 shares; 2026Q3: 2,317,741 shares 2,317,741$3.77M0.04%-778,595Timeline
STROSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 715,307 shares; 2026Q2: not reported; 2026Q3: 210,934 shares 210,934$3.4M0.03%newTimeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 73,607 shares 73,607$1.91M0.02%newTimeline
PTNPALATIN TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 70,000 shares; 2026Q1: 70,000 shares; 2026Q2: 62,124 shares; 2026Q3: 62,124 shares 62,124$551K0.01%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
BCRXBIOCRYST PHARMACEUTICALS INC15,827,186$158Mshares
WVEWAVE LIFE SCIENCES LTD26,975,505$157Mshares
NUVLNUVALENT INC1,246,456$154Mshares
NTLAINTELLIA THERAPEUTICS INC4,526,926$76.6Mshares
DFTXDEFINIUM THERAPEUTICS INC1,500,000$70.6Mshares
DMRADAMORA THERAPEUTICS INC2,399,702$62.4Mshares
AKTSAKTIS ONCOLOGY INC1,314,405$42.4Mshares
BIOABIOAGE LABS INC1,671,648$41Mshares
KPTIKARYOPHARM THERAPEUTICS INC1,917,354$18.7Mshares
WAYWAYSTAR HLDG CORP529,400$10.9Mshares
FRNMPERCEPTIVE CAP SOLUTIONS COR750,000$8.16Mshares
CRVSCORVUS PHARMACEUTICALS INC450,000$6.72Mshares
HOWLWEREWOLF THERAPEUTICS INC2,387,744$859Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-128411 base2026-11-16